Conference Coverage

VIDEO: ADA unifies all pediatric HbA1c targets to less than 7.5%


 

AT THE ADA ANNUAL SCIENTIFIC SESSIONS

SAN FRANCISCO – The American Diabetes Association has unified the pediatric hemoglobin A1c target values to less than 7.5% for all pediatric age groups, moving away from breaking down glycemic control targets by age. This will also harmonize the HbA1c goals with those of international groups such as the International Society of Pediatric and Adolescent Diabetes (ISPAD).

The change is part of a new position statement released on June 16 during the annual scientific sessions of the American Diabetes Association (Diabetes Care 2014;37:2034-54). The document also for the first time brings together recommendations for care of individuals with type 1 diabetes across all age groups.

In a video interview, Dr. Lori M.B. Laffel, one of the statement’s coauthors and chief of the pediatric, adolescent, and young adult section at Joslin Diabetes Center, Boston, explains the rationale behind this decision. Dr. David Maahs of the University of Colorado, Aurora, discusses the potential concern regarding the risk of hypoglycemia.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

nmiller@frontlinemedcom.com

On Twitter @naseemmiller

Recommended Reading

VIDEO: ACC/AHA lipid guidelines and diabetes
MDedge Internal Medicine
Diabetes found in 17% of MI patients in registry
MDedge Internal Medicine
Bionic pancreas beat standard insulin pump in type 1 diabetes
MDedge Internal Medicine
Novel combination drug IDegLira boosts glycemic control
MDedge Internal Medicine
Weight loss greater with higher-dose liraglutide in diabetes
MDedge Internal Medicine
Fatty heart may bring on diabetes
MDedge Internal Medicine
Cancer risk elevated before and 90 days after diabetes diagnosis
MDedge Internal Medicine
U.S. diabetes epidemic may be slowing
MDedge Internal Medicine
Insulin independence achieved with novel stem cell therapy
MDedge Internal Medicine
Closed-loop insulin delivery worked at home
MDedge Internal Medicine